Literature DB >> 18715905

Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization.

Wei Bu1, Diana Palmeri, Raghu Krishnan, Roxana Marin, Virginie M Aris, Patricia Soteropoulos, David M Lukac.   

Abstract

Lytic reactivation from latency is critical for the pathogenesis of Kaposi's sarcoma-associated herpesvirus (KSHV). We previously demonstrated that the 691-amino-acid (aa) KSHV Rta transcriptional transactivator is necessary and sufficient to reactivate the virus from latency. Viral lytic cycle genes, including those expressing additional transactivators and putative oncogenes, are induced in a cascade fashion following Rta expression. In this study, we sought to define Rta's direct targets during reactivation by generating a conditionally nuclear variant of Rta. Wild-type Rta protein is constitutively localized to cell nuclei and contains two putative nuclear localization signals (NLSs). Only one NLS (NLS2; aa 516 to 530) was required for the nuclear localization of Rta, and it relocalized enhanced green fluorescent protein exclusively to cell nuclei. The results of analyses of Rta NLS mutants demonstrated that proper nuclear localization of Rta was required for transactivation and the stimulation of viral reactivation. RTA with NLS1 and NLS2 deleted was fused to the hormone-binding domain of the murine estrogen receptor to generate an Rta variant whose nuclear localization and ability to transactivate and induce reactivation were tightly controlled posttranslationally by the synthetic hormone tamoxifen. We used this strategy in KSHV-infected cells treated with protein synthesis inhibitors to identify direct transcriptional targets of Rta. Rta activated only eight KSHV genes in the absence of de novo protein synthesis. These direct transcriptional targets of Rta were transactivated to different levels and included the genes nut-1/PAN, ORF57/Mta, ORF56/Primase, K2/viral interleukin-6 (vIL-6), ORF37/SOX, K14/vOX, K9/vIRF1, and ORF52. Our data suggest that the induction of most of the KSHV lytic cycle genes requires additional protein expression after the expression of Rta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715905      PMCID: PMC2573185          DOI: 10.1128/JVI.01012-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.

Authors:  Silvia Montaner; Akrit Sodhi; Alfredo Molinolo; Thomas H Bugge; Earl T Sawai; Yunsheng He; Yi Li; Patricio E Ray; J Silvio Gutkind
Journal:  Cancer Cell       Date:  2003-01       Impact factor: 31.743

2.  Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication.

Authors:  Yousang Gwack; Hiroyuki Nakamura; Sun Hwa Lee; John Souvlis; Jason T Yustein; Steve Gygi; Hsing-Jien Kung; Jae U Jung
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 3.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

4.  K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation.

Authors:  Wei Liao; Yong Tang; Su-Fan Lin; Hsing-Jien Kung; Chou-Zen Giam
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells.

Authors:  Ken Nishimura; Keiji Ueda; Shuhei Sakakibara; Eunju Do; Eriko Ohsaki; Toshiomi Okuno; Koichi Yamanishi
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

6.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

7.  Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

Authors:  Moon Jung Song; Hongyu Deng; Ren Sun
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Yanxing Yu; Gary S Hayward
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.

Authors:  Eric A Engels; Robert J Biggar; Vickie A Marshall; Michael A Walters; Christine J Gamache; Denise Whitby; James J Goedert
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

10.  Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.

Authors:  Hiroyuki Nakamura; Michael Lu; Yousang Gwack; John Souvlis; Steven L Zeichner; Jae U Jung
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  36 in total

1.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

2.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Authors:  Diana Palmeri; Kyla Driscoll Carroll; Olga Gonzalez-Lopez; David M Lukac
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.

Authors:  Adriana Forero; Kevin D McCormick; Frank J Jenkins; Saumendra N Sarkar
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

5.  Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.

Authors:  Sophia Spadavecchia; Olga Gonzalez-Lopez; Kyla Driscoll Carroll; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

6.  An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis.

Authors:  Alka Prasad; Michael Lu; David M Lukac; Steven L Zeichner
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

7.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

8.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

9.  Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.

Authors:  Duosha Hu; Victoria Wang; Min Yang; Shahed Abdullah; David A Davis; Thomas S Uldrick; Mark N Polizzotto; Ravindra P Veeranna; Stefania Pittaluga; Giovanna Tosato; Robert Yarchoan
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

10.  Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression.

Authors:  Virginie Bottero; Neelam Sharma-Walia; Nagaraj Kerur; Arun George Paul; Sathish Sadagopan; Mark Cannon; Bala Chandran
Journal:  Virology       Date:  2009-07-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.